Probing the Limits of Aptamer Affinity with a Microfluidic SELEX Platform

University of Helsinki, Finland
PLoS ONE (Impact Factor: 3.53). 11/2011; 6(11):e27051. DOI: 10.1371/journal.pone.0027051
Source: PubMed

ABSTRACT Nucleic acid-based aptamers offer many potential advantages relative to antibodies and other protein-based affinity reagents, including facile chemical synthesis, reversible folding, improved thermal stability and lower cost. However, their selection requires significant time and resources and selections often fail to yield molecules with affinities sufficient for molecular diagnostics or therapeutics. Toward a selection technique that can efficiently and reproducibly generate high performance aptamers, we have developed a microfluidic selection process (M-SELEX) that can be used to obtain high affinity aptamers against diverse protein targets. Here, we isolated DNA aptamers against three protein targets with different isoelectric points (pI) using a common protocol. After only three rounds of selection, we discovered novel aptamer sequences that bind to platelet derived growth factor B (PDGF-BB; pI = 9.3) and thrombin (pI = 8.3) with respective dissociation constants (K(d)) of 0.028 nM and 0.33 nM, which are both superior to previously reported aptamers against these targets. In parallel, we discovered a new aptamer that binds to apolipoprotein E3 (ApoE; pI = 5.3) with a K(d) of 3.1 nM. Furthermore, we observe that the net protein charge may exert influence on the affinity of the selected aptamers. To further explore this relationship, we performed selections against PDGF-BB under different pH conditions using the same selection protocol, and report an inverse correlation between protein charge and aptamer K(d).

  • Source
    • "However, it is often necessary to use a lot of animals for the production of antibodies, and these antibodies have several limitations in their chemical or physical stability, usefulness for all potential analytes, quality-assured preparations, and effective cost. As the emerging alternatives to antibodies, one can consider antimicrobial peptides (AMPs) [6] [7] [8], aptamers [9] [10], real-time quantitative polymerase chain reaction (PCR) [11], primers with micro-PCR chip [12], and peptide nucleic acid (PNA) probes [13]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Due to their ability of effective binding to multiple target microbes, the antimicrobial peptides (AMPs) have recently received lots of attention as an alternative to antibodies for detecting bacteria. We devel-oped a new biosensing method to detect Escherichia coli (E. coli) by implementing a microfluidic chip designed with a weir inside the channel, in which AMP-labeled microbeads were embedded. We char-acterized the detection rate of the stained E. coli within a certain period of time to examine the detection effectiveness of our device. As the flow rate of the bacterial suspension increases, the detection time to reach the saturation level decreases to less than 30 min, suggesting rapid detection, while the detection efficiency is maintained at a similar level. Except with very low concentrations of E. coli (<10 3 cells/mL), both the detection time and the efficiency do not depend on the E. coli concentration. Our method has the potential to be developed as a novel biosensing platform for rapid and accurate detection of pathogens.
    Sensors and Actuators B Chemical 10/2014; 191:211-218. DOI:10.1016/j.snb.2013.09.105 · 4.29 Impact Factor
  • Source
    Cancer Research 04/2011; 70(24 Supplement):PD02-08-PD02-08. DOI:10.1158/0008-5472.SABCS10-PD02-08 · 9.28 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study reports a microfluidic system which automatically performs the systematic evolution of ligands by exponential enrichment (SELEX) process for rapid screening of aptamers which are specific to cancer stem-like cells. The system utilizes magnetic bead-based techniques to select DNA aptamers and has several advantages including a rapid, automated screening process, and less consumption of cells and reagents. By integrating a microfluidic control module, a magnetic bead-based aptamer extraction module, and a temperature control module, the entire Cell-SELEX process can be performed in a shorter period of time. Compared with the traditional Cell-SELEX process, this microfluidic system is more efficient and consumes fewer sample volumes. It only takes approximately 3 days for an entire Cell-SELEX process with 15 screening runs, which is relatively faster than that of a traditional Cell-SELEX process (1 week for 15 rounds). The binding affinity of this resulting specific aptamer was measured by a flow cytometric analysis to have a dissociation constant (K d) of 15.32 nM. The capture rate for cancer stem-like cells using the specific aptamer-conjugated bead is better than that using Ber-EP4 antibody-conjugated bead. This microfluidic system may provide a powerful platform for the rapid screening of cell-specific aptamers.
    Microfluidics and Nanofluidics 03/2012; 14(3-4). DOI:10.1007/s10404-012-1095-3 · 2.67 Impact Factor
Show more

Preview (2 Sources)

Available from